Sadhana Nitro Chem Limited Schedules Board Meeting on April 29, 2026 for Director Appointments and Fund Raising
Sadhana Nitro Chem Limited has scheduled a board meeting for April 29, 2026, to consider director appointments including regularisation of Mrs. Sindhu Suneer Kotian as Independent Director and continuation of Mr. Asit Dhankumar Javeri as Executive Director beyond 70 years. The board will also deliberate on increasing authorized share capital and raising funds through preferential issue to support business financial requirements. An extraordinary general meeting or postal ballot may be convened for shareholder approval of matters arising from the board discussions.

*this image is generated using AI for illustrative purposes only.
Sadhana nitrochem has intimated the stock exchanges about a board meeting scheduled for April 29, 2026, to transact several important corporate matters under Regulation 29 of the SEBI (LODR) Regulations, 2015. The meeting will address key governance and financial decisions that require board approval.
Director Appointments and Continuation
The board will consider two significant director-related matters during the meeting. The first involves the regularisation of appointment of Mrs. Sindhu Suneer Kotian (DIN: 08918862) as Non-Executive Independent Director of the company. Additionally, the board will deliberate on the continuation of Mr. Asit Dhankumar Javeri (DIN: 00268114) in his office as Executive Director upon his attaining the age of 70+ years.
| Director Matter: | Details |
|---|---|
| New Independent Director: | Mrs. Sindhu Suneer Kotian (DIN: 08918862) |
| Position: | Non-Executive Independent Director |
| Continuing Executive Director: | Mr. Asit Dhankumar Javeri (DIN: 00268114) |
| Age Consideration: | Continuation beyond 70+ years |
Capital Structure and Fund Raising
The meeting agenda includes consideration and approval of an increase in the company's authorized share capital. This move appears to be linked to the company's fund raising plans through a preferential issue. The board will evaluate raising funds through preferential issue to support the financial requirements of the business operations.
The fund raising initiative will be conducted in accordance with applicable provisions of the Companies Act, 2013, Securities Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other relevant laws. The board will decide and approve the allotment process following regulatory compliance requirements.
Shareholder Approval Process
The company has indicated its intention to convene an Extraordinary General Meeting or initiate a postal ballot process to seek shareholder approval for matters that may arise during the board discussions. This demonstrates the company's commitment to maintaining proper corporate governance and ensuring shareholder participation in significant decisions.
Meeting Details
The board meeting intimation was signed by Company Secretary Nitin Rameshchandra Jani (Membership No.: A4757) on April 24, 2026. The meeting is scheduled for Wednesday, April 29, 2026, and will also address any other business that may arise during the discussions.
Historical Stock Returns for Sadhana Nitrochem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.40% | +12.73% | +78.42% | -72.69% | -89.18% | -88.99% |
What specific business expansion or strategic initiatives is Sadhana Nitrochem planning that necessitates the increase in authorized share capital and preferential fund raising?
How might the preferential issue pricing and dilution impact existing shareholders' equity stakes and the company's market valuation?
Will the continuation of Mr. Asit Dhankumar Javeri beyond 70+ years signal a succession planning strategy or indicate challenges in leadership transition?


































